Akebia Therapeutics, Inc. (AKBA)
NASDAQ: AKBA · Real-Time Price · USD
3.690
+0.050 (1.37%)
At close: Jun 5, 2025, 4:00 PM
3.690
0.00 (0.00%)
After-hours: Jun 5, 2025, 4:32 PM EDT

Akebia Therapeutics Stock Forecast

Stock Price Forecast

According to 5 professional analysts, the 12-month price target for Akebia Therapeutics stock ranges from a low of $6.00 to a high of $8.00. The average analyst price target of $6.90 forecasts a 86.99% increase in the stock price over the next year.

Price Target: $6.90 (+86.99%)
Analyst Consensus: Strong Buy
Target Low Average Median High
Price $6.00 $6.90 $7.00 $8.00
Change +62.60% +86.99% +89.70% +116.80%

Analyst Ratings

The average analyst rating for Akebia Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Jan '25Feb '25Mar '25Apr '25May '25Jun '25
Strong Buy 111223
Buy 001222
Hold 000000
Sell 000000
Strong Sell 000000
Total 112445

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Initiates
$8
Strong Buy Initiates $8 +116.80% Jun 4, 2025
Leerink Partners
Leerink Partners
Buy
Initiates
$7
Buy Initiates $7 +89.70% Apr 28, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$7.5
Strong Buy Reiterates $7.5 +103.25% Apr 4, 2025
Jefferies
Jefferies
Strong Buy
Initiates
$6
Strong Buy Initiates $6 +62.60% Apr 1, 2025
Piper Sandler
Piper Sandler
Buy
Maintains
$4$6
Buy Maintains $4$6 +62.60% Mar 14, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
197.53M
from 160.18M
Increased by 23.32%
Revenue Next Year
296.09M
from 197.53M
Increased by 49.90%
EPS This Year
-0.17
from -0.33
EPS Next Year
n/a
from -0.17
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
294.64M211.65M292.48M194.62M160.18M197.53M296.09M330.84M
Revenue Growth
-12.05%-28.17%38.19%-33.46%-17.70%23.32%49.90%11.74%
EPS
-2.78-1.70-0.52-0.28-0.33-0.17-0.18
EPS Growth
--------
Forward PE
-------20.67
No. Analysts
-----766
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026202720282029
High 216.5M 415.3M 404.9M
Avg 197.5M 296.1M 330.8M
Low 174.8M 205.2M 262.4M

Revenue Growth

Revenue Growth 20252026202720282029
High
35.1%
110.3%
36.7%
Avg
23.3%
49.9%
11.7%
Low
9.1%
3.9%
-11.4%

EPS Forecast

EPS 2025202620272028
High -0.06 0.44 0.37
Avg -0.17 - 0.18
Low -0.35 -0.31 -0.22

EPS Growth

EPS Growth 2025202620272028
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.